Compounds > ruthenium
Page last updated: 2024-08-22

ruthenium and Granulocytic Leukemia, Chronic

ruthenium has been researched along with Granulocytic Leukemia, Chronic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Guo, B; Hu, G; Huang, Y; Liu, HK; Lv, M; Qian, Y; Su, Z; Xue, X1
Castilho, N; de Melo, ACC; de Oliveira, GAP; de Souza, ÍP; Gabriel, P; Marques, MA; Moraes, AH; Nunes, KJRC; Pereira-Maia, EC; Rodrigues, BL; Santana, JMSVP; Terenzi, H1
Carvalho, BP; Dos Santos, WB; Pereira, LC; Porto, HK; Silveira-Lacerda, Ede P; Vilanova-Costa, CA1
Boyle, PH; Cream, CW; Davies, RJ; Kavanagh, YT; Kelly, JM; Lawler, MP; O'Keeffe, CM; Stevenson, C1

Other Studies

4 other study(ies) available for ruthenium and Granulocytic Leukemia, Chronic

ArticleYear
Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells.
    Journal of inorganic biochemistry, 2023, Volume: 243

    Topics: Azides; CD47 Antigen; Humans; Immunization; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phagocytosis; Ruthenium

2023
New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents.
    Molecules (Basel, Switzerland), 2019, Jun-07, Volume: 24, Issue:11

    Topics: Antineoplastic Agents; Circular Dichroism; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Organometallic Compounds; Proto-Oncogene Proteins c-abl; Ruthenium; Spectrometry, Mass, Electrospray Ionization; src Homology Domains; Sulfamethoxypyridazine; X-Ray Diffraction

2019
MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes.
    Biological trace element research, 2015, Volume: 163, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cisplatin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ruthenium

2015
Targeting of photooxidative damage on single-stranded DNA representing the bcr-abl chimeric gene using oligonucleotide-conjugates containing [Ru(phen)3](2+)-like photosensitiser groups.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2002, Volume: 1, Issue:12

    Topics: Autoradiography; Base Sequence; Chromatography, High Pressure Liquid; Densitometry; DNA Damage; DNA, Single-Stranded; Genes, abl; Guanine; Humans; In Situ Hybridization; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleic Acid Conformation; Oligonucleotides, Antisense; Organometallic Compounds; Oxidation-Reduction; Photochemistry; Photosensitizing Agents; Ruthenium

2002